Skip to main content
Clinical Trials/JPRN-UMIN000019077
JPRN-UMIN000019077
Completed
Phase 1

Safety of Percutaneous Cryoablation in Patients with Painful Bone and Soft Tissue Tumors: A Single Center Prospective Study (SCIRO-1502) - Cryoablation for painful bone and soft tissue tumors (SCIRO-1502)

Okayama University Hospital0 sites10 target enrollmentDecember 1, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Painful bone and soft tissue tumor
Sponsor
Okayama University Hospital
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2015
End Date
December 14, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Vital organ and/or vessel on the needle route. 2\) Patient has the following comorbidities. a) Heart failure (NYHA \>\= III) b) Active infection except for virus hepatitis 3\) Body temperature of 38 degree or more. 4\) Target lesion is not able to be evaluated with imagings. 5\) Pregnant. 6\) Worse bone fracture caused by cryoablation. 7\) Worse quality of life caused by cryoablation. 8\) Inadequate cardiac, hepatic, renal, respiratory, coagulation, and bone marrow functions. 9\) Not eligible determined by the responding physician.

Outcomes

Primary Outcomes

Not specified

Similar Trials